Literature DB >> 21169004

Proteostenosis and plasma cell pathophysiology.

Simone Cenci1, Eelco van Anken, Roberto Sitia.   

Abstract

Plasma cells differentiate from B lymphocytes to sustain antibody production. As professional secretors, they allow dissecting proteostasis in the exocytic compartment, the stresses that protein production entails and their possible roles in signaling. Most plasma cells are short-lived to limit antibody responses. After a few days of intense immunoglobulin production, they undergo apoptosis, offering a unique model of cellular senescence. Recent observations reveal that proteotoxic stresses physiologically contribute to regulate their biogenesis, function and lifespan, explaining partly the sensitivity of multiple myeloma cells to proteasome inhibitors. This essay summarizes these plasma cell lessons, and their general implications for the regulation of proteostasis, cell senescence and cancer therapeutics.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21169004     DOI: 10.1016/j.ceb.2010.11.004

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  18 in total

Review 1.  Proteasome inhibitors: an expanding army attacking a unique target.

Authors:  Alexei F Kisselev; Wouter A van der Linden; Herman S Overkleeft
Journal:  Chem Biol       Date:  2012-01-27

2.  Editorial: Proteostenosis: cancer's Achilles heel?

Authors:  Jonathan W Yewdell; Alexandre David
Journal:  J Leukoc Biol       Date:  2012-11       Impact factor: 4.962

3.  Plasma cells require autophagy for sustainable immunoglobulin production.

Authors:  Niccolò Pengo; Maria Scolari; Laura Oliva; Enrico Milan; Federica Mainoldi; Andrea Raimondi; Claudio Fagioli; Arianna Merlini; Elisabetta Mariani; Elena Pasqualetto; Ugo Orfanelli; Maurilio Ponzoni; Roberto Sitia; Stefano Casola; Simone Cenci
Journal:  Nat Immunol       Date:  2013-01-27       Impact factor: 25.606

4.  Cross talk between immunoglobulin heavy-chain transcription and RNA surveillance during B cell development.

Authors:  Aurélien Tinguely; Guillaume Chemin; Sophie Péron; Christophe Sirac; Stéphane Reynaud; Michel Cogné; Laurent Delpy
Journal:  Mol Cell Biol       Date:  2011-10-28       Impact factor: 4.272

Review 5.  The myeloma stem cell concept, revisited: from phenomenology to operational terms.

Authors:  Hans Erik Johnsen; Martin Bøgsted; Alexander Schmitz; Julie Støve Bødker; Tarec Christoffer El-Galaly; Preben Johansen; Peter Valent; Niklas Zojer; Els Van Valckenborgh; Karin Vanderkerken; Mark van Duin; Pieter Sonneveld; Martin Perez-Andres; Alberto Orfao; Karen Dybkær
Journal:  Haematologica       Date:  2016-11-10       Impact factor: 9.941

Review 6.  Thiol/disulfide redox states in signaling and sensing.

Authors:  Young-Mi Go; Dean P Jones
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-01-29       Impact factor: 8.250

7.  A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis.

Authors:  Julie Støve Bødker; Rasmus Froberg Brøndum; Alexander Schmitz; Anna Amanda Schönherz; Ditte Starberg Jespersen; Mads Sønderkær; Charles Vesteghem; Hanne Due; Caroline Holm Nørgaard; Martin Perez-Andres; Mehmet Kemal Samur; Faith Davies; Brian Walker; Charlotte Pawlyn; Martin Kaiser; David Johnson; Uta Bertsch; Annemiek Broyl; Mark van Duin; Rajen Shah; Preben Johansen; Martin Agge Nørgaard; Richard J Samworth; Pieter Sonneveld; Hartmut Goldschmidt; Gareth J Morgan; Alberto Orfao; Nikhil Munshi; Hans Erik Johnson; Tarec El-Galaly; Karen Dybkær; Martin Bøgsted
Journal:  Blood Adv       Date:  2018-09-25

Review 8.  Autophagy in plasma cell pathophysiology.

Authors:  Laura Oliva; Simone Cenci
Journal:  Front Immunol       Date:  2014-03-12       Impact factor: 7.561

9.  Biochemical nature of Russell Bodies.

Authors:  Maria Francesca Mossuto; Diletta Ami; Tiziana Anelli; Claudio Fagioli; Silvia Maria Doglia; Roberto Sitia
Journal:  Sci Rep       Date:  2015-07-30       Impact factor: 4.379

Review 10.  Plasma cell biology: Foundations for targeted therapeutic development in transplantation.

Authors:  Amy P Rossi; Rita R Alloway; David Hildeman; E Steve Woodle
Journal:  Immunol Rev       Date:  2021-07-12       Impact factor: 10.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.